Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12351
CALL
Invesco WilderHill Clean Energy ETF
PBW
$465M
| $50K | ﹤0.01% |
2,500
-3,200
| -56% | -$65.2K |
|
|
EVRI
12352
CALL
DELISTED
Everi Holdings
EVRI
| $50K | ﹤0.01% |
3,700
-700
| -16% | -$9.36K |
|
|
MTLS
12353
PUT
Materialise
MTLS
$400M
| $50K | ﹤0.01% |
7,100
-1,200
| -14% | -$7.93K |
|
|
ADN
12354
DELISTED
Advent Technologies
ADN
| $50K | ﹤0.01% |
+9,991
| New | +$41.3K |
|
12355
PUT
Celularity
CELU
$20.1M
| $49.9K | ﹤0.01% |
24,000
+23,800
| +11,900% | +$56.8K |
|
|
STRR
12356
DELISTED
Star Equity Holdings
STRR
| $49.9K | ﹤0.01% |
+22,078
| New | +$71.6K |
|
12357
PUT
NatWest
NWG
$75.9B
| $49.8K | ﹤0.01% |
4,900
+3,900
| +390% | +$38.6K |
|
12358
PUT
Comtech Telecommunications
CMTL
$52.7M
| $49.7K | ﹤0.01% |
12,400
+2,100
| +20% | +$7.5K |
|
12359
CALL
Dimensional World ex US Core Equity 2 ETF
DFAX
$12.5B
| $49.7K | ﹤0.01% |
+2,000
| New | +$51.7K |
|
12360
PUT
Inovio Pharmaceuticals
INO
$113M
| $49.7K | ﹤0.01% |
27,160
-15,508
| -36% | -$68.6K |
|
|
ZYXI
12361
PUT
DELISTED
Zynex
ZYXI
| $49.7K | ﹤0.01% |
6,200
+6,000
| +3,000% | +$49.4K |
|
12362
Roma Green Finance Ltd
ROMA
$544M
| $49.6K | ﹤0.01% |
67,994
-25,690
| -27% | -$22K |
|
12363
International Paper
IP
$21.6B
| $49.5K | ﹤0.01% |
920
-301,853
| -100% | -$16.2M |
|
12364
PUT
iRadimed
IRMD
$1.11B
| $49.5K | ﹤0.01% |
+900
| New | +$47.4K |
|
12365
PUT
Global X SuperDividend ETF
SDIV
$1.21B
| $49.5K | ﹤0.01% |
2,400
+1,400
| +140% | +$30.7K |
|
12366
PUT
American Well
AMWL
$212M
| $49.3K | ﹤0.01% |
+6,800
| New | +$61.6K |
|
12367
CALL
Acumen Pharmaceuticals
ABOS
$193M
| $49.2K | ﹤0.01% |
28,600
+25,700
| +886% | +$61.9K |
|
12368
ClearSign Technologies
CLIR
$31.7M
| $49.2K | ﹤0.01% |
+3,413
| New | +$33.7K |
|
12369
CALL
Tredegar Corp
TG
$276M
| $49.2K | ﹤0.01% |
6,400
+6,100
| +2,033% | +$46.4K |
|
12370
Orchestra BioMed
OBIO
$265M
| $49.1K | ﹤0.01% |
12,279
-7,836
| -39% | -$42.1K |
|
12371
CALL
Verastem
VSTM
$596M
| $49.1K | ﹤0.01% |
9,500
+4,500
| +90% | +$17.7K |
|
12372
CALL
Avantis International Equity ETF
AVDE
$18.8B
| $49.1K | ﹤0.01% |
+800
| New | +$51.2K |
|
12373
CALL
Hooker Furnishings Corp
HOFT
$158M
| $49K | ﹤0.01% |
+3,500
| New | +$58.9K |
|
12374
CALL
Nektar Therapeutics
NKTR
$2.49B
| $49K | ﹤0.01% |
3,513
+2,660
| +312% | +$46.9K |
|
|
MTA
12375
PUT
Metalla Royalty & Streaming
MTA
$912M
| $48.9K | ﹤0.01% |
19,500
-13,200
| -40% | -$41.9K |
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.